ArticleFrontiers in microbiology2026
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Crude oil-contaminated soils harbor bacteria with specialized hydrocarbon-degrading capabilities, yet the Methods: The complete genome was sequenced using Illumina MiSeq and assembled into a single closed contig (4,564,481 bp; G+C content 66.59%; GenBank: CP031167). Genome quality was assessed with BUSCO v6.0.0 and CheckM2. Species boundaries were evaluated using average nucleotide identity (ANIb via JSpeciesWS) and digital DNA-DNA hybridization (dDDH via GGDC Formula 2) against 38 representative Results: BUSCO completeness was 99.7% and CheckM2 confirmed 100.0% completeness with 0.0% contamination. Despite 99.86% 16S rRNA gene identity to Discussion: Collectively, the genomic, phylogenomic, and phenotypic evidence supports ASS1 as the type strain of a novel species,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.